Have you or a loved one taken Oxbryta (voxelotor) for the treatment of sickle cell disease and experienced unexpected or serious health complications? Oxbryta was approved to help improve hemoglobin levels in individuals with sickle cell disease, offering hope to many patients suffering from this life-threatening condition. However, growing concerns have emerged over potential side effects and adverse reactions linked to the drug—some of which may not have been fully disclosed by the manufacturer. Patients have reported a range of complications, raising questions about the drug’s long-term safety and the adequacy of its warnings. If you or someone you know has used Oxbryta and suffered health issues as a result, you may be eligible for financial compensation. Our legal team is investigating claims nationwide and working to hold pharmaceutical companies accountable for any harm caused. Complete the form above to learn if you qualify—you pay nothing unless we win your case.
Limited Time – Claim Now & Fill Out the Form!
